Nasus Pharma is trading 9.1% down at $3.18 today in an apparent pullback following a sharp two-day rally and in the absence of any fresh, company-specific news or filings.
- The move appears to be driven by profit-taking and inherent volatility in a thinly traded small-cap stock rather than a shift in fundamentals.
- The decline occurs while broader markets trade mixed and the healthcare sector is modestly higher, further suggesting the drop is isolated to recent price action.